Skip to main content
. 2016 Jul 4;6(7):e217. doi: 10.1038/nutd.2016.25

Figure 2.

Figure 2

(a) Proportion of patients achieving glycemic goal* after 1 year of treatment by region. (b) Mean change in HbA1c after 1 year of treatment by region (ITT population). Overall data are taken from ITT population and cohort data are taken from PP population. *HbA1c<7.0% without hypoglycemia or weight gain ⩾3% in patients with baseline HbA1c ⩾7.0% (SEP). HbA1c, glycated hemoglobin; ITT, intention-to treat; OAD, oral antidiabetes drug; PP, per protocol; SEP, secondary effectiveness end point.